About IntusCare
IntusCare is a private company based in Providence, Rhode Island. It has reported $25,205,822 raised in five offerings on Form D since January 2023. Its chief executive is John Felton.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 31, 2026 | $539,433of $1.0M target | 6 | $89,906 | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Apr 18, 2025 | May 5, 2025 | $24,181fully sold | 1 | $24,181 | Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 1, 2024 | Nov 14, 2024 | $11,119,567of $12.3M target | 10 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Dec 5, 2022 | May 29, 2024amended Oct 10, 2024 | $438,011fully sold | 5 | $87,602 | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 2, 2022 | Jan 18, 2023 | $13,084,630of $23.4M target | 14 | $934K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $25,205,822 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on IntusCare's Form D filed Mar 31, 2026.
JF
John Felton
President and Chief Executive Officer, director
JF
David Feinberg
Chairman of Oracle Health
JH
Julian Harris
Director
Earlier filings also listed William Helman (director, last listed Nov 2024) and Evan Jackson (executive officer and director, last listed Nov 2024).